Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CPAH

CounterPath (CPAH) Stock Price, News & Analysis

CounterPath logo

About CounterPath Stock (NASDAQ:CPAH)

Advanced Chart

Key Stats

Today's Range
$3.47
$3.49
50-Day Range
$3.44
$3.49
52-Week Range
$1.84
$5.92
Volume
74,600 shs
Average Volume
31,350 shs
Market Capitalization
$22.41 million
P/E Ratio
34.80
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CPAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CounterPath and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CPAH Stock News Headlines

Think Out Loud
Why CounterPath (CPAH) Stock Is Soaring Today
Prepare for the “Mar-a-Lago Accord” Money Shock
Why Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.tc pixel
See More Headlines

CPAH Stock Analysis - Frequently Asked Questions

CounterPath Co. (NASDAQ:CPAH) issued its earnings results on Wednesday, December, 14th. The software maker reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.10) by $0.02. The software maker earned $2.75 million during the quarter, compared to analyst estimates of $3.30 million. CounterPath had a trailing twelve-month return on equity of 25.68% and a net margin of 5.30%.

Based on aggregate information from My MarketBeat watchlists, some other companies that CounterPath investors own include FuelCell Energy (FCEL), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV) and XTI Aerospace (XTIA).

Company Calendar

Last Earnings
12/14/2016
Today
9/16/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged Software
Sub-Industry
N/A
Current Symbol
NASDAQ:CPAH
CIK
1236997
Fax
N/A
Employees
72
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
34.80
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.10 million
Net Margins
5.30%
Pretax Margin
N/A
Return on Equity
25.68%
Return on Assets
5.61%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.60

Sales & Book Value

Annual Sales
$12.10 million
Price / Sales
1.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.33 per share
Price / Book
10.55

Miscellaneous

Outstanding Shares
6,440,000
Free Float
N/A
Market Cap
$22.41 million
Optionable
Not Optionable
Beta
1.76
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:CPAH) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners